Fig. 2From: Impact of prediabetes and diabetes on 3-year outcome of patients treated with new-generation drug-eluting stents in two large-scale randomized clinical trials Kaplan–Meier event curves for target vessel failure and its individual components at 3-year follow-up. Kaplan–Meier event curves for target vessel failure and its individual components up to 3-year follow-up showing higher rates of the main endpoint in patients with prediabetes and diabetes as compared to patients with normoglycemia Back to article page